10/18/2024

Janusmed sex and gender

Janusmed sex and gender – imiquimod

Janusmed Sex and Gender is a knowledge database providing information on sex and gender aspects of drug treatment. The knowledge database is primarily intended to be used by physicians and healthcare professionals. The texts are general and should not be considered as treatment guidelines. The individual patient’s physician is responsible for the patient’s drug treatment.

Back to index
A A
A A

Imiquimod

Imiquimod

Class : A

Show all info

Print

Contact us

  1. Perry CM, Lamb HM. Topical imiquimod: a review of its use in genital warts. Drugs. 1999;58:375-90.

  2. Roozeboom MH, Nelemans PJ, Mosterd K, Steijlen PM, Arits AH, Kelleners-Smeets NW. Photodynamic therapy vs topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a noninferiority randomized controlled trial. Br J Dermatol. 2015;172:739-45.

  3. Erlendsson AM, Egekvist H, Lorentzen HF, Philipsen PA, Stausbøl-Grøn B, Stender IM et al. Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics. Int J Dermatol. 2016;55:309-16.

  4. Javor S, Chimenti S, Patrizi A, Stingeni L, Pellacani G, Cavicchini S et al. Relapsed actinic keratosis evaluation: an observational Italian multicenter prospective study Does gender have a role?. G Ital Dermatol Venereol. 2014;149:199-204.

  5. Sauder DN, Skinner RB, Fox TL, Owens ML. Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations. Sex Transm Dis. 2003;30:124-8.

  6. ALDARA (imiquimod). Summary of Product Characteristics. European Medicines Agency (EMA); 2016

  7. Gotovtseva EP, Kapadia AS, Smolensky MH, Lairson DR. Optimal frequency of imiquimod (aldara) 5% cream for the treatment of external genital warts in immunocompetent adults: a meta-analysis. Sex Transm Dis. 2008;35:346-51.

  8. Edwards L, Ferenczy A, Eron L, Baker D, Owens ML, Fox TL et al. Self-administered topical 5% imiquimod cream for external anogenital warts HPV Study Group Human PapillomaVirus. Arch Dermatol. 1998;134:25-30.

  9. Beutner KR, Tyring SK, Trofatter KF, Douglas JM, Spruance S, Owens ML et al. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts. Antimicrob Agents Chemother. 1998;42:789-94.

  10. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2015 [cited 2017-03-02.]

  1. Perry CM, Lamb HM. Topical imiquimod: a review of its use in genital warts. Drugs. 1999;58:375-90.
  2. Roozeboom MH, Nelemans PJ, Mosterd K, Steijlen PM, Arits AH, Kelleners-Smeets NW. Photodynamic therapy vs topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a noninferiority randomized controlled trial. Br J Dermatol. 2015;172:739-45.
  3. Erlendsson AM, Egekvist H, Lorentzen HF, Philipsen PA, Stausbøl-Grøn B, Stender IM et al. Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics. Int J Dermatol. 2016;55:309-16.
  4. Javor S, Chimenti S, Patrizi A, Stingeni L, Pellacani G, Cavicchini S et al. Relapsed actinic keratosis evaluation: an observational Italian multicenter prospective study Does gender have a role?. G Ital Dermatol Venereol. 2014;149:199-204.
  5. Sauder DN, Skinner RB, Fox TL, Owens ML. Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations. Sex Transm Dis. 2003;30:124-8.
  6. ALDARA (imiquimod). Summary of Product Characteristics. European Medicines Agency (EMA); 2016
  7. Gotovtseva EP, Kapadia AS, Smolensky MH, Lairson DR. Optimal frequency of imiquimod (aldara) 5% cream for the treatment of external genital warts in immunocompetent adults: a meta-analysis. Sex Transm Dis. 2008;35:346-51.
  8. Edwards L, Ferenczy A, Eron L, Baker D, Owens ML, Fox TL et al. Self-administered topical 5% imiquimod cream for external anogenital warts HPV Study Group Human PapillomaVirus. Arch Dermatol. 1998;134:25-30.
  9. Beutner KR, Tyring SK, Trofatter KF, Douglas JM, Spruance S, Owens ML et al. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts. Antimicrob Agents Chemother. 1998;42:789-94.
  10. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2015 [cited 2017-03-02.]